Global Diabetes Drugs Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
Page: 122
Published Date: 06 Jun 2021
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
The Diabetes Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Diabetes Drugs size is estimated to be XX million in 2021 from USD 52510 million in 2020, with a change of XX% between 2020 and 2021. The global Diabetes Drugs market size is expected to grow at a CAGR of 5.3% for the next five years.
Market segmentation
Diabetes Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Insulin
DPP-4
GLP-1
SGLT-2
Market segment by Application can be divided into
Type 1 Diabetes
Type 2 Diabetes
The key market players for global Diabetes Drugs market are listed below:
Sanofi
AstraZeneca
Bayer
Biocon
Boehringer Ingelheim
Dongbao Pharmaceutical
Eli Lilly
Ganlee
Ginwa
Guangzhou Baiyun Mountain
Hisun Pharmacy
Hua Dong
Huadong Medicine
Jumpcan Pharmacy
KELUN
Merck & Co.
MSD
North China Pharmaceutical Group Corporation
Novartis
Novo Nordisk
Sanofi
SHIJIAZHUANG YILING PHARMACEUTICAL
Takeda
Taloph
Tianan Pharmaceutical
Tonghua DongBao
Wanbang Biopharmaceuticals
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Diabetes Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Diabetes Drugs, with price, sales, revenue and global market share of Diabetes Drugs from 2019 to 2021.
Chapter 3, the Diabetes Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Diabetes Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Diabetes Drugs market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Diabetes Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Diabetes Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Diabetes Drugs Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Insulin
1.2.3 DPP-4
1.2.4 GLP-1
1.2.5 SGLT-2
1.3 Market Analysis by Application
1.3.1 Overview: Global Diabetes Drugs Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Type 1 Diabetes
1.3.3 Type 2 Diabetes
1.4 Global Diabetes Drugs Market Size & Forecast
1.4.1 Global Diabetes Drugs Sales in Value (2016-2026))
1.4.2 Global Diabetes Drugs Sales in Volume (2016-2026)
1.4.3 Global Diabetes Drugs Price by Type (2016-2026) & (USD/Unit)
1.5 Global Diabetes Drugs Production Capacity Analysis
1.5.1 Global Diabetes Drugs Total Production Capacity (2016-2026)
1.5.2 Global Diabetes Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Diabetes Drugs Market Drivers
1.6.2 Diabetes Drugs Market Restraints
1.6.3 Diabetes Drugs Trends Analysis
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business
2.1.3 Sanofi Diabetes Drugs Product and Services
2.1.4 Sanofi Diabetes Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 AstraZeneca
2.2.1 AstraZeneca Details
2.2.2 AstraZeneca Major Business
2.2.3 AstraZeneca Diabetes Drugs Product and Services
2.2.4 AstraZeneca Diabetes Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Bayer
2.3.1 Bayer Details
2.3.2 Bayer Major Business
2.3.3 Bayer Diabetes Drugs Product and Services
2.3.4 Bayer Diabetes Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Biocon
2.4.1 Biocon Details
2.4.2 Biocon Major Business
2.4.3 Biocon Diabetes Drugs Product and Services
2.4.4 Biocon Diabetes Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Boehringer Ingelheim
2.5.1 Boehringer Ingelheim Details
2.5.2 Boehringer Ingelheim Major Business
2.5.3 Boehringer Ingelheim Diabetes Drugs Product and Services
2.5.4 Boehringer Ingelheim Diabetes Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Dongbao Pharmaceutical
2.6.1 Dongbao Pharmaceutical Details
2.6.2 Dongbao Pharmaceutical Major Business
2.6.3 Dongbao Pharmaceutical Diabetes Drugs Product and Services
2.6.4 Dongbao Pharmaceutical Diabetes Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Eli Lilly
2.7.1 Eli Lilly Details
2.7.2 Eli Lilly Major Business
2.7.3 Eli Lilly Diabetes Drugs Product and Services
2.7.4 Eli Lilly Diabetes Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Ganlee
2.8.1 Ganlee Details
2.8.2 Ganlee Major Business
2.8.3 Ganlee Diabetes Drugs Product and Services
2.8.4 Ganlee Diabetes Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Ginwa
2.9.1 Ginwa Details
2.9.2 Ginwa Major Business
2.9.3 Ginwa Diabetes Drugs Product and Services
2.9.4 Ginwa Diabetes Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Guangzhou Baiyun Mountain
2.10.1 Guangzhou Baiyun Mountain Details
2.10.2 Guangzhou Baiyun Mountain Major Business
2.10.3 Guangzhou Baiyun Mountain Diabetes Drugs Product and Services
2.10.4 Guangzhou Baiyun Mountain Diabetes Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 Hisun Pharmacy
2.11.1 Hisun Pharmacy Details
2.11.2 Hisun Pharmacy Major Business
2.11.3 Hisun Pharmacy Diabetes Drugs Product and Services
2.11.4 Hisun Pharmacy Diabetes Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 Hua Dong
2.12.1 Hua Dong Details
2.12.2 Hua Dong Major Business
2.12.3 Hua Dong Diabetes Drugs Product and Services
2.12.4 Hua Dong Diabetes Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.13 Huadong Medicine
2.13.1 Huadong Medicine Details
2.13.2 Huadong Medicine Major Business
2.13.3 Huadong Medicine Diabetes Drugs Product and Services
2.13.4 Huadong Medicine Diabetes Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.14 Jumpcan Pharmacy
2.14.1 Jumpcan Pharmacy Details
2.14.2 Jumpcan Pharmacy Major Business
2.14.3 Jumpcan Pharmacy Diabetes Drugs Product and Services
2.14.4 Jumpcan Pharmacy Diabetes Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.15 KELUN
2.15.1 KELUN Details
2.15.2 KELUN Major Business
2.15.3 KELUN Diabetes Drugs Product and Services
2.15.4 KELUN Diabetes Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.16 Merck & Co.
2.16.1 Merck & Co. Details
2.16.2 Merck & Co. Major Business
2.16.3 Merck & Co. Diabetes Drugs Product and Services
2.16.4 Merck & Co. Diabetes Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.17 MSD
2.17.1 MSD Details
2.17.2 MSD Major Business
2.17.3 MSD Diabetes Drugs Product and Services
2.17.4 MSD Diabetes Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.18 North China Pharmaceutical Group Corporation
2.18.1 North China Pharmaceutical Group Corporation Details
2.18.2 North China Pharmaceutical Group Corporation Major Business
2.18.3 North China Pharmaceutical Group Corporation Diabetes Drugs Product and Services
2.18.4 North China Pharmaceutical Group Corporation Diabetes Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.19 Novartis
2.19.1 Novartis Details
2.19.2 Novartis Major Business
2.19.3 Novartis Diabetes Drugs Product and Services
2.19.4 Novartis Diabetes Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.20 Novo Nordisk
2.20.1 Novo Nordisk Details
2.20.2 Novo Nordisk Major Business
2.20.3 Novo Nordisk Diabetes Drugs Product and Services
2.20.4 Novo Nordisk Diabetes Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.21 Sanofi
2.21.1 Sanofi Details
2.21.2 Sanofi Major Business
2.21.3 Sanofi Diabetes Drugs Product and Services
2.21.4 Sanofi Diabetes Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.22 SHIJIAZHUANG YILING PHARMACEUTICAL
2.22.1 SHIJIAZHUANG YILING PHARMACEUTICAL Details
2.22.2 SHIJIAZHUANG YILING PHARMACEUTICAL Major Business
2.22.3 SHIJIAZHUANG YILING PHARMACEUTICAL Diabetes Drugs Product and Services
2.22.4 SHIJIAZHUANG YILING PHARMACEUTICAL Diabetes Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.23 Takeda
2.23.1 Takeda Details
2.23.2 Takeda Major Business
2.23.3 Takeda Diabetes Drugs Product and Services
2.23.4 Takeda Diabetes Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.24 Taloph
2.24.1 Taloph Details
2.24.2 Taloph Major Business
2.24.3 Taloph Diabetes Drugs Product and Services
2.24.4 Taloph Diabetes Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.25 Tianan Pharmaceutical
2.25.1 Tianan Pharmaceutical Details
2.25.2 Tianan Pharmaceutical Major Business
2.25.3 Tianan Pharmaceutical Diabetes Drugs Product and Services
2.25.4 Tianan Pharmaceutical Diabetes Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.26 Tonghua DongBao
2.26.1 Tonghua DongBao Details
2.26.2 Tonghua DongBao Major Business
2.26.3 Tonghua DongBao Diabetes Drugs Product and Services
2.26.4 Tonghua DongBao Diabetes Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.27 Wanbang Biopharmaceuticals
2.27.1 Wanbang Biopharmaceuticals Details
2.27.2 Wanbang Biopharmaceuticals Major Business
2.27.3 Wanbang Biopharmaceuticals Diabetes Drugs Product and Services
2.27.4 Wanbang Biopharmaceuticals Diabetes Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3.1 Global Diabetes Drugs Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Diabetes Drugs Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Diabetes Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Diabetes Drugs Manufacturer Market Share
3.4.2 Top 6 Diabetes Drugs Manufacturer Market Share
3.5 Global Diabetes Drugs Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Diabetes Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4.1 Global Diabetes Drugs Market Size by Region
4.1.1 Global Diabetes Drugs Sales in Volume by Region (2016-2026)
4.1.2 Global Diabetes Drugs Revenue by Region (2016-2026)
4.2 North America Diabetes Drugs Revenue (2016-2026)
4.3 Europe Diabetes Drugs Revenue (2016-2026)
4.4 Asia-Pacific Diabetes Drugs Revenue (2016-2026)
4.5 South America Diabetes Drugs Revenue (2016-2026)
4.6 Middle East and Africa Diabetes Drugs Revenue (2016-2026)
5.1 Global Diabetes Drugs Sales in Volume by Type (2016-2026)
5.2 Global Diabetes Drugs Revenue by Type (2016-2026)
5.3 Global Diabetes Drugs Price by Type (2016-2026)
6.1 Global Diabetes Drugs Sales in Volume by Application (2016-2026)
6.2 Global Diabetes Drugs Revenue by Application (2016-2026)
6.3 Global Diabetes Drugs Price by Application (2016-2026)
7.1 North America Diabetes Drugs Sales by Type (2016-2026)
7.2 North America Diabetes Drugs Sales by Application (2016-2026)
7.3 North America Diabetes Drugs Market Size by Country
7.3.1 North America Diabetes Drugs Sales in Volume by Country (2016-2026)
7.3.2 North America Diabetes Drugs Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8.1 Europe Diabetes Drugs Sales by Type (2016-2026)
8.2 Europe Diabetes Drugs Sales by Application (2016-2026)
8.3 Europe Diabetes Drugs Market Size by Country
8.3.1 Europe Diabetes Drugs Sales in Volume by Country (2016-2026)
8.3.2 Europe Diabetes Drugs Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9.1 Asia-Pacific Diabetes Drugs Sales by Type (2016-2026)
9.2 Asia-Pacific Diabetes Drugs Sales by Application (2016-2026)
9.3 Asia-Pacific Diabetes Drugs Market Size by Region
9.3.1 Asia-Pacific Diabetes Drugs Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Diabetes Drugs Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10.1 South America Diabetes Drugs Sales by Type (2016-2026)
10.2 South America Diabetes Drugs Sales by Application (2016-2026)
10.3 South America Diabetes Drugs Market Size by Country
10.3.1 South America Diabetes Drugs Sales in Volume by Country (2016-2026)
10.3.2 South America Diabetes Drugs Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11.1 Middle East & Africa Diabetes Drugs Sales by Type (2016-2026)
11.2 Middle East & Africa Diabetes Drugs Sales by Application (2016-2026)
11.3 Middle East & Africa Diabetes Drugs Market Size by Country
11.3.1 Middle East & Africa Diabetes Drugs Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Diabetes Drugs Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Diabetes Drugs Typical Distributors
12.3 Diabetes Drugs Typical Customers
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Diabetes Drugs Revenue by Type, (USD Million), 2021-2026
Table 2. Global Diabetes Drugs Revenue by Application, (USD Million), 2021-2026
Table 3. Sanofi Basic Information, Manufacturing Base and Competitors
Table 4. Sanofi Major Business
Table 5. Sanofi Diabetes Drugs Product and Services
Table 6. Sanofi Diabetes Drugs Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 8. AstraZeneca Major Business
Table 9. AstraZeneca Diabetes Drugs Product and Services
Table 10. AstraZeneca Diabetes Drugs Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Bayer Basic Information, Manufacturing Base and Competitors
Table 12. Bayer Major Business
Table 13. Bayer Diabetes Drugs Product and Services
Table 14. Bayer Diabetes Drugs Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Biocon Basic Information, Manufacturing Base and Competitors
Table 16. Biocon Major Business
Table 17. Biocon Diabetes Drugs Product and Services
Table 18. Biocon Diabetes Drugs Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 20. Boehringer Ingelheim Major Business
Table 21. Boehringer Ingelheim Diabetes Drugs Product and Services
Table 22. Boehringer Ingelheim Diabetes Drugs Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Dongbao Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 24. Dongbao Pharmaceutical Major Business
Table 25. Dongbao Pharmaceutical Diabetes Drugs Product and Services
Table 26. Dongbao Pharmaceutical Diabetes Drugs Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 28. Eli Lilly Major Business
Table 29. Eli Lilly Diabetes Drugs Product and Services
Table 30. Eli Lilly Diabetes Drugs Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Ganlee Basic Information, Manufacturing Base and Competitors
Table 32. Ganlee Major Business
Table 33. Ganlee Diabetes Drugs Product and Services
Table 34. Ganlee Diabetes Drugs Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Ginwa Basic Information, Manufacturing Base and Competitors
Table 36. Ginwa Major Business
Table 37. Ginwa Diabetes Drugs Product and Services
Table 38. Ginwa Diabetes Drugs Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Guangzhou Baiyun Mountain Basic Information, Manufacturing Base and Competitors
Table 40. Guangzhou Baiyun Mountain Major Business
Table 41. Guangzhou Baiyun Mountain Diabetes Drugs Product and Services
Table 42. Guangzhou Baiyun Mountain Diabetes Drugs Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Hisun Pharmacy Basic Information, Manufacturing Base and Competitors
Table 44. Hisun Pharmacy Major Business
Table 45. Hisun Pharmacy Diabetes Drugs Product and Services
Table 46. Hisun Pharmacy Diabetes Drugs Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Hua Dong Basic Information, Manufacturing Base and Competitors
Table 48. Hua Dong Major Business
Table 49. Hua Dong Diabetes Drugs Product and Services
Table 50. Hua Dong Diabetes Drugs Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Huadong Medicine Basic Information, Manufacturing Base and Competitors
Table 52. Huadong Medicine Major Business
Table 53. Huadong Medicine Diabetes Drugs Product and Services
Table 54. Huadong Medicine Diabetes Drugs Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Jumpcan Pharmacy Basic Information, Manufacturing Base and Competitors
Table 56. Jumpcan Pharmacy Major Business
Table 57. Jumpcan Pharmacy Diabetes Drugs Product and Services
Table 58. Jumpcan Pharmacy Diabetes Drugs Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. KELUN Basic Information, Manufacturing Base and Competitors
Table 60. KELUN Major Business
Table 61. KELUN Diabetes Drugs Product and Services
Table 62. KELUN Diabetes Drugs Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. Merck & Co. Basic Information, Manufacturing Base and Competitors
Table 64. Merck & Co. Major Business
Table 65. Merck & Co. Diabetes Drugs Product and Services
Table 66. Merck & Co. Diabetes Drugs Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 67. MSD Basic Information, Manufacturing Base and Competitors
Table 68. MSD Major Business
Table 69. MSD Diabetes Drugs Product and Services
Table 70. MSD Diabetes Drugs Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 71. North China Pharmaceutical Group Corporation Basic Information, Manufacturing Base and Competitors
Table 72. North China Pharmaceutical Group Corporation Major Business
Table 73. North China Pharmaceutical Group Corporation Diabetes Drugs Product and Services
Table 74. North China Pharmaceutical Group Corporation Diabetes Drugs Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 75. Novartis Basic Information, Manufacturing Base and Competitors
Table 76. Novartis Major Business
Table 77. Novartis Diabetes Drugs Product and Services
Table 78. Novartis Diabetes Drugs Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 79. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 80. Novo Nordisk Major Business
Table 81. Novo Nordisk Diabetes Drugs Product and Services
Table 82. Novo Nordisk Diabetes Drugs Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 83. Sanofi Basic Information, Manufacturing Base and Competitors
Table 84. Sanofi Major Business
Table 85. Sanofi Diabetes Drugs Product and Services
Table 86. Sanofi Diabetes Drugs Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 87. SHIJIAZHUANG YILING PHARMACEUTICAL Basic Information, Manufacturing Base and Competitors
Table 88. SHIJIAZHUANG YILING PHARMACEUTICAL Major Business
Table 89. SHIJIAZHUANG YILING PHARMACEUTICAL Diabetes Drugs Product and Services
Table 90. SHIJIAZHUANG YILING PHARMACEUTICAL Diabetes Drugs Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 91. Takeda Basic Information, Manufacturing Base and Competitors
Table 92. Takeda Major Business
Table 93. Takeda Diabetes Drugs Product and Services
Table 94. Takeda Diabetes Drugs Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 95. Taloph Basic Information, Manufacturing Base and Competitors
Table 96. Taloph Major Business
Table 97. Taloph Diabetes Drugs Product and Services
Table 98. Taloph Diabetes Drugs Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 99. Tianan Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 100. Tianan Pharmaceutical Major Business
Table 101. Tianan Pharmaceutical Diabetes Drugs Product and Services
Table 102. Tianan Pharmaceutical Diabetes Drugs Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 103. Tonghua DongBao Basic Information, Manufacturing Base and Competitors
Table 104. Tonghua DongBao Major Business
Table 105. Tonghua DongBao Diabetes Drugs Product and Services
Table 106. Tonghua DongBao Diabetes Drugs Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 107. Wanbang Biopharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 108. Wanbang Biopharmaceuticals Major Business
Table 109. Wanbang Biopharmaceuticals Diabetes Drugs Product and Services
Table 110. Wanbang Biopharmaceuticals Diabetes Drugs Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 111. Global Diabetes Drugs Sales by Manufacturer (2019-2021e) & (M Units)
Table 112. Global Diabetes Drugs Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 113. Market Position of Manufacturers in Diabetes Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 114. Global Diabetes Drugs Production Capacity by Company, (M Units): 2020 VS 2021
Table 115. Head Office and Diabetes Drugs Production Site of Key Manufacturer
Table 116. Diabetes Drugs New Entrant and Capacity Expansion Plans
Table 117. Diabetes Drugs Mergers & Acquisitions in the Past Five Years
Table 118. Global Diabetes Drugs Sales by Region (2016-2021e) & (M Units)
Table 119. Global Diabetes Drugs Sales by Region (2021-2026) & (M Units)
Table 120. Global Diabetes Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 121. Global Diabetes Drugs Revenue by Region (2021-2026) & (USD Million)
Table 122. Global Diabetes Drugs Sales by Type (2016-2021e) & (M Units)
Table 123. Global Diabetes Drugs Sales by Type (2021-2026) & (M Units)
Table 124. Global Diabetes Drugs Revenue by Type (2016-2021e) & (USD Million)
Table 125. Global Diabetes Drugs Revenue by Type (2021-2026) & (USD Million)
Table 126. Global Diabetes Drugs Price by Type (2016-2021e) & (USD/Unit)
Table 127. Global Diabetes Drugs Price by Type (2021-2026) & (USD/Unit)
Table 128. Global Diabetes Drugs Sales by Application (2016-2021e) & (M Units)
Table 129. Global Diabetes Drugs Sales by Application (2021-2026) & (M Units)
Table 130. Global Diabetes Drugs Revenue by Application (2016-2021e) & (USD Million)
Table 131. Global Diabetes Drugs Revenue by Application (2021-2026) & (USD Million)
Table 132. Global Diabetes Drugs Price by Application (2016-2021e) & (USD/Unit)
Table 133. Global Diabetes Drugs Price by Application (2021-2026) & (USD/Unit)
Table 134. North America Diabetes Drugs Sales by Country (2016-2021e) & (M Units)
Table 135. North America Diabetes Drugs Sales by Country (2021-2026) & (M Units)
Table 136. North America Diabetes Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 137. North America Diabetes Drugs Revenue by Country (2021-2026) & (USD Million)
Table 138. North America Diabetes Drugs Sales by Type (2016-2021e) & (M Units)
Table 139. North America Diabetes Drugs Sales by Type (2021-2026) & (M Units)
Table 140. North America Diabetes Drugs Sales by Application (2016-2021e) & (M Units)
Table 141. North America Diabetes Drugs Sales by Application (2021-2026) & (M Units)
Table 142. Europe Diabetes Drugs Sales by Country (2016-2021e) & (M Units)
Table 143. Europe Diabetes Drugs Sales by Country (2021-2026) & (M Units)
Table 144. Europe Diabetes Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 145. Europe Diabetes Drugs Revenue by Country (2021-2026) & (USD Million)
Table 146. Europe Diabetes Drugs Sales by Type (2016-2021e) & (M Units)
Table 147. Europe Diabetes Drugs Sales by Type (2021-2026) & (M Units)
Table 148. Europe Diabetes Drugs Sales by Application (2016-2021e) & (M Units)
Table 149. Europe Diabetes Drugs Sales by Application (2021-2026) & (M Units)
Table 150. Asia-Pacific Diabetes Drugs Sales by Region (2016-2021e) & (M Units)
Table 151. Asia-Pacific Diabetes Drugs Sales by Region (2021-2026) & (M Units)
Table 152. Asia-Pacific Diabetes Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 153. Asia-Pacific Diabetes Drugs Revenue by Region (2021-2026) & (USD Million)
Table 154. Asia-Pacific Diabetes Drugs Sales by Type (2016-2021e) & (M Units)
Table 155. Asia-Pacific Diabetes Drugs Sales by Type (2021-2026) & (M Units)
Table 156. Asia-Pacific Diabetes Drugs Sales by Application (2016-2021e) & (M Units)
Table 157. Asia-Pacific Diabetes Drugs Sales by Application (2021-2026) & (M Units)
Table 158. South America Diabetes Drugs Sales by Country (2016-2021e) & (M Units)
Table 159. South America Diabetes Drugs Sales by Country (2021-2026) & (M Units)
Table 160. South America Diabetes Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 161. South America Diabetes Drugs Revenue by Country (2021-2026) & (USD Million)
Table 162. South America Diabetes Drugs Sales by Type (2016-2021e) & (M Units)
Table 163. South America Diabetes Drugs Sales by Type (2021-2026) & (M Units)
Table 164. South America Diabetes Drugs Sales by Application (2016-2021e) & (M Units)
Table 165. South America Diabetes Drugs Sales by Application (2021-2026) & (M Units)
Table 166. Middle East & Africa Diabetes Drugs Sales by Country (2016-2021e) & (M Units)
Table 167. Middle East & Africa Diabetes Drugs Sales by Country (2021-2026) & (M Units)
Table 168. Middle East & Africa Diabetes Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 169. Middle East & Africa Diabetes Drugs Revenue by Country (2021-2026) & (USD Million)
Table 170. Middle East & Africa Diabetes Drugs Sales by Type (2016-2021e) & (M Units)
Table 171. Middle East & Africa Diabetes Drugs Sales by Type (2021-2026) & (M Units)
Table 172. Middle East & Africa Diabetes Drugs Sales by Application (2016-2021e) & (M Units)
Table 173. Middle East & Africa Diabetes Drugs Sales by Application (2021-2026) & (M Units)
Table 174. Direct Channel Pros & Cons
Table 175. Indirect Channel Pros & Cons
Table 176. Diabetes Drugs Typical Distributors
Table 177. Diabetes Drugs Typical Customers
List of Figures
Figure 1. Diabetes Drugs Picture
Figure 2. Global Diabetes Drugs Sales Market Share by Type in 2020
Figure 3. Insulin
Figure 4. DPP-4
Figure 5. GLP-1
Figure 6. SGLT-2
Figure 7. Global Diabetes Drugs Sales Market Share by Application in 2020
Figure 8. Type 1 Diabetes
Figure 9. Type 2 Diabetes
Figure 10. Global Diabetes Drugs Market Size, (USD Million) & (M Units): 2020 VS 2021 VS 2026
Figure 11. Global Diabetes Drugs Market Size and Forecast (2016-2026) & (USD Million)
Figure 12. Global Diabetes Drugs Sales (2016-2026) & (M Units)
Figure 13. Global Diabetes Drugs Price by Type (2016-2026) & (USD/Unit)
Figure 14. Global Diabetes Drugs Production Capacity (2016-2026) & (M Units)
Figure 15. Global Diabetes Drugs Production Capacity by Geographic Region: 2020 VS 2021
Figure 16. Diabetes Drugs Market Drivers
Figure 17. Diabetes Drugs Market Restraints
Figure 18. Diabetes Drugs Market Trends
Figure 19. Global Diabetes Drugs Sales Market Share by Manufacturer in 2020
Figure 20. Global Diabetes Drugs Revenue Market Share by Manufacturer in 2020
Figure 21. Diabetes Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 22. Top 3 Diabetes Drugs Manufacturer (Revenue) Market Share in 2020
Figure 23. Top 6 Diabetes Drugs Manufacturer (Revenue) Market Share in 2020
Figure 24. Global Diabetes Drugs Sales Market Share by Region (2016-2026)
Figure 25. Global Diabetes Drugs Revenue Market Share by Region (2016-2026)
Figure 26. North America Diabetes Drugs Revenue (2016-2026) & (USD Million)
Figure 27. Europe Diabetes Drugs Revenue (2016-2026) & (USD Million)
Figure 28. Asia-Pacific Diabetes Drugs Revenue (2016-2026) & (USD Million)
Figure 29. South America Diabetes Drugs Revenue (2016-2026) & (USD Million)
Figure 30. Middle East & Africa Diabetes Drugs Revenue (2016-2026) & (USD Million)
Figure 31. Global Diabetes Drugs Sales Market Share by Type (2016-2026)
Figure 32. Global Diabetes Drugs Revenue Market Share by Type (2016-2026)
Figure 33. Global Diabetes Drugs Price by Type (2016-2026) & (USD/Unit)
Figure 34. Global Diabetes Drugs Sales Market Share by Application (2016-2026)
Figure 35. Global Diabetes Drugs Revenue Market Share by Application (2016-2026)
Figure 36. Global Diabetes Drugs Price by Application (2016-2026) & (USD/Unit)
Figure 37. North America Diabetes Drugs Sales Market Share by Type (2016-2026)
Figure 38. North America Diabetes Drugs Sales Market Share by Application (2016-2026)
Figure 39. North America Diabetes Drugs Sales Market Share by Country (2016-2026)
Figure 40. North America Diabetes Drugs Revenue Market Share by Country (2016-2026)
Figure 41. United States Diabetes Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Canada Diabetes Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Mexico Diabetes Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Europe Diabetes Drugs Sales Market Share by Type (2016-2026)
Figure 45. Europe Diabetes Drugs Sales Market Share by Application (2016-2026)
Figure 46. Europe Diabetes Drugs Sales Market Share by Country (2016-2026)
Figure 47. Europe Diabetes Drugs Revenue Market Share by Country (2016-2026)
Figure 48. Germany Diabetes Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. France Diabetes Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. United Kingdom Diabetes Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Russia Diabetes Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Italy Diabetes Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Asia-Pacific Diabetes Drugs Sales Market Share by Region (2016-2026)
Figure 54. Asia-Pacific Diabetes Drugs Sales Market Share by Application (2016-2026)
Figure 55. Asia-Pacific Diabetes Drugs Sales Market Share by Region (2016-2026)
Figure 56. Asia-Pacific Diabetes Drugs Revenue Market Share by Region (2016-2026)
Figure 57. China Diabetes Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Japan Diabetes Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Korea Diabetes Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. India Diabetes Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Southeast Asia Diabetes Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Australia Diabetes Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. South America Diabetes Drugs Sales Market Share by Type (2016-2026)
Figure 64. South America Diabetes Drugs Sales Market Share by Application (2016-2026)
Figure 65. South America Diabetes Drugs Sales Market Share by Country (2016-2026)
Figure 66. South America Diabetes Drugs Revenue Market Share by Country (2016-2026)
Figure 67. Brazil Diabetes Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Argentina Diabetes Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Middle East & Africa Diabetes Drugs Sales Market Share by Type (2016-2026)
Figure 70. Middle East & Africa Diabetes Drugs Sales Market Share by Application (2016-2026)
Figure 71. Middle East & Africa Diabetes Drugs Sales Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Diabetes Drugs Revenue Market Share by Country (2016-2026)
Figure 73. Turkey Diabetes Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Egypt Diabetes Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Saudi Arabia Diabetes Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. South Africa Diabetes Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Sales Channel: Direct Channel vs Indirect Channel
Figure 78. Methodology
Figure 79. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Sanofi AstraZeneca Bayer Biocon Boehringer Ingelheim Dongbao Pharmaceutical Eli Lilly Ganlee Ginwa Guangzhou Baiyun Mountain Hisun Pharmacy Hua Dong Huadong Medicine Jumpcan Pharmacy KELUN Merck & Co. MSD North China Pharmaceutical Group Corporation Novartis Novo Nordisk Sanofi SHIJIAZHUANG YILING PHARMACEUTICAL Takeda Taloph Tianan Pharmaceutical Tonghua DongBao Wanbang Biopharmaceuticals
Related Reports
04 Jan 2022
Pharma & Healthcare
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
